Piro et al. have suggested that TAK1 is associated with the resistance to preoperative chemoradiotherapy of the patients with esophageal adenocarcinoma, and TAK1 can significantly reduce the apoptosis level of the tumor cells via promoting the expression of BIRC3 [37]. This evidence concerns the gene BIRC3 and esophageal adenocarcinoma.